HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Additive benefit of glycoprotein IIb/IIIa inhibition and adjunctive thrombus aspiration during primary coronary intervention: results of the Initial Thrombosuction and Tirofiban Infusion (ITTI) trial.

AbstractBACKGROUND:
Thrombus aspiration has been shown to provide significant benefits during primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). The aim of the current study was to evaluate the additional benefit of tirofiban to thrombus aspiration during primary PCI in myocardial reperfusion.
METHODS:
100 STEMI patients were randomized according to a 2 × 2 factorial design into 1 of the 4 groups: standard PCI, PCI with initial thrombus aspiration (IT), PCI with tirofiban infusion (TI), and PCI with both treatments (IT+TI).
RESULTS:
The myocardial blush grade (MBG) 3 was achieved in 30.4%, 45.8%, 56% and 78.6% in the 4 groups respectively. More frequent MBG 3 (p=0.015) and complete (>70%) ST-segment resolution (STR, 67.9% vs. 41.7%, p=0.058) were observed in IT ± TI group compared with IT group. If actuarial analysis was done after reassigning the 2 TI patients who crossed over to IT+TI, the difference between IT+TI and IT groups became more significant (MBG 3 rates: 76.7% vs. 45.8%, p=0.009; complete STR rates: 70% vs. 41.7%, p=0.036). Infusion of tirofiban resulted in improved MBG and STR (p=0.003 and 0.037, respectively). Thrombus aspiration resulted in improved MBG only (p=0.048) but not in STR. 6-month MACE (death, reinfarction, target lesion revascularization and stroke) was similar among groups (p=0.725).
CONCLUSIONS:
Tirofiban may augment thrombus aspiration therapy on myocardial reperfusion in primary PCI. The benefit of thrombus aspiration treatment without tirofiban might be less significant, especially on resolution of ST-segment elevation.
AuthorsChung-Pin Liu, Mao-Shin Lin, Yu-Wei Chiu, Jen-Kuang Lee, Chih-Neng Hsu, Chi-Shen Hung, Hsien-Li Kao
JournalInternational journal of cardiology (Int J Cardiol) Vol. 156 Issue 2 Pg. 174-9 (Apr 19 2012) ISSN: 1874-1754 [Electronic] Netherlands
PMID21131072 (Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
CopyrightCopyright © 2010 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Platelet Glycoprotein GPIIb-IIIa Complex
  • Tyrosine
  • Tirofiban
Topics
  • Adult
  • Aged
  • Combined Modality Therapy (methods)
  • Coronary Thrombosis (drug therapy, metabolism, surgery)
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Glycoprotein GPIIb-IIIa Complex (antagonists & inhibitors, metabolism)
  • Prospective Studies
  • Suction
  • Tirofiban
  • Treatment Outcome
  • Tyrosine (analogs & derivatives, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: